Search

Author/Creator Ritchlin, C.

1. AB0747 Early and Sustained Modified PSARC Response in Psoriatic Arthritis Patients Treated with Ustekinumab: Results from PSUMMIT 1 and PSUMMIT 2. (10th June 2014)

Authors:
McInnes, I.; Ritchlin, C.; Rahman, P.; Puig, L.; Gottlieb, A.B.; Song, M.; Randazzo, B.; Li, S.; Wang, Y.; Mendelsohn, A.; Kavanaugh, A.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 73:Supplement 2(2014)
Page Start:
1051
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. AB0921 Impact of baseline demographics, disease activity and concomitant medication on american college of rheumatology 20 response rate and health assessment questionnaire-disability index score with tofacitinib in active psoriatic arthritis: a pooled subgroup analysis of 2 phase 3 studies. (12th June 2018)

Authors:
Behrens, F.; Gomez-Reino, J.; Nash, P.; Gladman, D.D.; FitzGerald, O.; Ritchlin, C.; Kudlacz, E.; Wu, J.; Wang, C.; Romero, A.B.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 77(2018)Supplement 2
Page Start:
1585
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. FRI0456 Association between Improvement in Enthesopathy and Quality of Life: Results from Anti-Tnf-Naïve Patients with Psoriatic Arthritis in Two Phase 3 Ustekinumab Trials. (15th July 2016)

Authors:
McInnes, I.B.; Puig, L.; Gottlieb, A.B.; Ritchlin, C.; You, Y.; Song, M.; Kafka, S.; Tang, K.L.; Morgan, G.J.; Rahman, P.; Kavanaugh, A.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 75(2016)Supplement 2
Page Start:
601
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. OP0001 Maintenance of Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis Despite Prior Conventional Nonbiologic and Anti-TNF Biologic Therapy: 1 Yr Results of the Psummit 2 Trial. (23rd January 2014)

Authors:
Ritchlin, C.; McInnes, I.; Kavanaugh, A.; Puig, L.; Rahman, P.; Li, S.; Shen, Y.; Doyle, M.; Mendelsohn, A.; Gottlieb, A.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A48
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. OP0079 Ustekinumab is Effective in Inhibiting Radiographic Progression in Patients with Active Psoriatic Arthritis: Integrated Data Analysis of Two Phase 3, Randomized, Placebo-Controlled Studies. (10th June 2014)

Authors:
McInnes, I.; Ritchlin, C.; Rahman, P.; Puig, L.; Gottlieb, A.; Song, M.; Randazzo, B.; Li, S.; Wang, Y.; Mendelsohn, A.M.; Kavanaugh, A.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 73:Supplement 2(2014)
Page Start:
91
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. OP0110 Treat-To-Target Recommendations for Spondyloarthritis, Including Ankylosing Spondylitis and Psoriatic Arthritis: A Consensus of an International Task Force. (23rd January 2014)

Authors:
Smolen, J. S.; Braun, J.; Dougados, M.; Emery, P.; FitzGerald, O.; Helliwell, P.; Kavanaugh, A.; Kvien, T. K.; Landewé, R.; Luger, T.; Mease, P.; Olivieri, I.; Reveille, J.; Ritchlin, C.; Rudwaleit, M.; Schoels, M.; Sieper, J.; de Wit, M.; van der Heijde, D.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A88
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. OP0158 Ustekinumab in patients with active psoriatic arthritis: Results of the phase 3, multicenter, double-blind, placebo-controlled psummit I study. (23rd January 2014)

Authors:
McInnes, I.B.; Kavanaugh, A.; Gottlieb, A.B.; Puig, L.; Rahman, P.; Ritchlin, C.; Li, S.; Wang, Y.; Mendelsohn, A.M.; Doyle, M.K.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 71(2012)Supplement 3
Page Start:
107
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. OP0174 Efficacy and Safety of Ustekinumab in Psoriatic Arthritis Patients with Spondylitis and Peripheral Joint Involvement: Results from a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study. (9th June 2015)

Authors:
Kavanaugh, A.; Puig, L.; Gottlieb, A.B.; Ritchlin, C.; You, Y.; Wang, Y.; Mendelsohn, A.M.; Song, M.; Rahman, P.; McInnes, I.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 74(2015)Supplement 2
Page Start:
136
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. SAT0267 Safety of Ustekinumab from the Placebo-Controlled Periods of Psoriatic Arthritis and Psoriasis Clinical Developmental Programs. (23rd January 2014)

Authors:
McInnes, I.; Papp, K.; Puig, L.; Reich, K.; Ritchlin, C.; Strober, B.; Rahman, P.; Kavanaugh, A.; Mendelsohn, A.; Song, M.; Chan, D.; Shen, Y. K.; Li, S.; Gottlieb, A. B.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A673
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. SAT0271 Continued Improvement of Signs and Symptoms in Ustekinumab-Treated Patients with Active Psoriatic Arthritis: Week 52 Results of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study. (23rd January 2014)

Authors:
Kavanaugh, A.; McInnes, I. B.; Gottlieb, A. B.; Puig, L.; Rahman, P.; Ritchlin, C.; Li, S.; Wang, Y.; Doyle, M.; Mendelsohn, A.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A674
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗